JP2010503409A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010503409A5 JP2010503409A5 JP2009528468A JP2009528468A JP2010503409A5 JP 2010503409 A5 JP2010503409 A5 JP 2010503409A5 JP 2009528468 A JP2009528468 A JP 2009528468A JP 2009528468 A JP2009528468 A JP 2009528468A JP 2010503409 A5 JP2010503409 A5 JP 2010503409A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cancer
- composition according
- peptide
- azurin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84435806P | 2006-09-14 | 2006-09-14 | |
| PCT/US2007/078371 WO2008033987A2 (en) | 2006-09-14 | 2007-09-13 | Compositions and methods to prevent cancer with cupredoxins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013209725A Division JP2014050390A (ja) | 2006-09-14 | 2013-10-04 | クプレドキシンによって癌を予防する組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010503409A JP2010503409A (ja) | 2010-02-04 |
| JP2010503409A5 true JP2010503409A5 (enExample) | 2010-11-04 |
Family
ID=39184582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528468A Withdrawn JP2010503409A (ja) | 2006-09-14 | 2007-09-13 | クプレドキシンによって癌を予防する組成物および方法 |
| JP2013209725A Pending JP2014050390A (ja) | 2006-09-14 | 2013-10-04 | クプレドキシンによって癌を予防する組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013209725A Pending JP2014050390A (ja) | 2006-09-14 | 2013-10-04 | クプレドキシンによって癌を予防する組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2061498A4 (enExample) |
| JP (2) | JP2010503409A (enExample) |
| KR (1) | KR20090059152A (enExample) |
| CN (1) | CN101595124A (enExample) |
| AU (1) | AU2007296429A1 (enExample) |
| BR (1) | BRPI0714987A2 (enExample) |
| CA (1) | CA2663498A1 (enExample) |
| IL (1) | IL197602A0 (enExample) |
| MX (1) | MX2009002787A (enExample) |
| NO (1) | NO20091267L (enExample) |
| RU (1) | RU2009113812A (enExample) |
| SG (1) | SG174784A1 (enExample) |
| WO (1) | WO2008033987A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
| US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
| US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
| US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
| UA97466C2 (ru) | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| US8232244B2 (en) | 2007-02-08 | 2012-07-31 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
| US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
| US9598470B2 (en) * | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
| EP1904642A4 (en) | 2005-07-19 | 2008-11-26 | Univ Illinois | TRANSPORT AGENTS FOR CROSS-BREAKING BLOOD-BRAIN DISEASE AND INTRUSION IN BRAIN CANCER CELLS AND METHOD OF USE THEREOF |
| AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
| CA3075836A1 (en) * | 2017-09-29 | 2019-04-04 | Oncgnostics Gmbh | Risk determination for neoplasia and cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
| UA97466C2 (ru) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| AU2006277009A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| WO2007024368A2 (en) * | 2005-07-19 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to control angiogenesis with cupredoxins |
-
2007
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/ko not_active Withdrawn
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/pt not_active Application Discontinuation
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/ja not_active Withdrawn
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en not_active Ceased
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/es not_active Application Discontinuation
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/ru unknown
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/zh active Pending
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/no not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009113812A (ru) | Композиции и способы для профилактики рака с помощью купредоксинов | |
| US6669951B2 (en) | Compositions and methods for enhancing drug delivery across and into epithelial tissues | |
| ES2989204T3 (es) | Pautas posológicas para la administración de análogos del péptido 2 similar al glucagón (GLP-2) | |
| RU2009125599A (ru) | Композиции и способы лечения рака cpg-богатой днк и купредоксинами | |
| KR102741242B1 (ko) | 국소 조성물 및 용도 | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| WO2019126542A1 (en) | Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders | |
| EA039105B1 (ru) | Катионные нейротоксины | |
| AU2002306500A1 (en) | Transporters comprising spaced arginine moieties | |
| WO2002065986A2 (en) | Transporters comprising spaced arginine moieties | |
| ES2818824T3 (es) | Composiciones que comprenden una proteína de fusión de VIP-ELP para su uso en el tratamiento de fibrosis quística | |
| JP2014050390A5 (enExample) | ||
| CA3148827A1 (en) | Compositions and methods of using c/ebp alpha sarna | |
| CN102482323B (zh) | 新型肽及其应用 | |
| WO2004108088A3 (en) | Methods and compositions for interferon therapy | |
| CN121646602A (zh) | 靶向dll3的肽及其构建体 | |
| US20200188451A1 (en) | OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS | |
| CN106924260B (zh) | 化合物在制备用于治疗脑胶质瘤的药物中的用途 | |
| TW202039531A (zh) | 用於治療平滑肌功能不良之組成物及方法 | |
| CN114364691B (zh) | 作为纤维化基质积累的抑制剂的肽 | |
| TWI496579B (zh) | 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途 | |
| ES2842523T3 (es) | Métodos y composiciones para el tratamiento de la artritis | |
| US20210070803A1 (en) | Modified peptides and associated methods of use | |
| Oshima et al. | Design, synthesis and biological evaluation of negatively charged 111In-DTPA-octreotide derivatives | |
| US10793601B2 (en) | Therapeutic spalt-like transcription factor 4 (SALL4) peptide |